Medicamen Biotech Ltd.

View in App
635.05 +0.60 ▲0.1%

01 December 2023, 04:01:00 PM
Volume: 608

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.medicamen.com
Market Cap 801.70 Cr.
Enterprise Value(EV) 830.72 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 11.12 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 57.01 Trailing Twelve Months Ending 2023-09
Industry PE 38.75 Trailing Twelve Months Ending 2023-09
Book Value / Share 152.43 Trailing Twelve Months Ending 2023-09
Price to Book Value 4.16 Calculated using Price: 633.70
Dividend Yield 0.16 Period Ending 2023-03
No. of Shares Subscribed 1.27 Cr. 12,651,100 Shares
FaceValue 10
About Medicamen Biotech Ltd.
Medicamen Biotech Limited was incorporated in December 1993, it is a widely held, Globaly Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. Medicamen Biotech Limited is committed to produce and provide quality medicines at competitive price for domestic as well as international markets thereby being socially responsible and rendering services to the medical fraternity since inception.

Medicamen Biotech Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Medicamen Biotech Ltd. Performance

View details >>
1 Day
+0.09%
1 Week
-0.72%
1 Month
-4.93%
3 Month
-14.08%
6 Month
-9.97%
1 Year
-25.75%
2 Year
+8.26%
5 Year
+38.17%
10 Year
+6089.57%

Medicamen Biotech Ltd. Fundamental Ratios

View details >>
5 years 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 13.95 12.94 9.89 11.25 9.06
Return on Capital Employed (%) 19.30 16.54 12.99 12.94 10.86
Return on Assets (%) 8.80 8.36 6.46 7.11 5.87

Medicamen Biotech Ltd. Balance Sheet

View details >>
Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 87 121 133 146 193 200
Non Curr. Liab. 1 4 8 6 1 1
Curr. Liab. 49 56 53 73 83 94
Minority Int. 0
Equity & Liab. 137 181 194 225 277 295
Non Curr. Assets 40 75 91 94 106 119
Curr. Assets 96 104 96 123 163 176
Misc. Exp. not W/O 0 2 7 8 7
Total Assets 137 181 194 225 277 295

Medicamen Biotech Ltd. Profit and Loss

View details >>
Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 123 126 113 115 141 160
Other Income 4 2 1 2 2 2
Total Income 126 127 113 117 143 162
Total Expenditure -105 -106 -93 -91 -117 -136
PBIDT 21 21 20 26 27 26
Interest -1 -1 -2 -2 -3 -3
Depreciation -2 -3 -3 -6 -6 -7
Taxation -6 -5 -4 -3 -2 -3
Exceptional Items
PAT 12 13 12 15 15 13
Minority Interest 1
Share Associate
Other Related Items
Consolidated Net Profit 12 13 12 15 15 14
Adjusted EPS 10 11 10 12 12 11

Medicamen Biotech Ltd. Cash Flow

View details >>
Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 4 13 13 4 -6
Cash Fr. Inv. -15 -37 -18 -8 -6
Cash Fr. Finan. -4 19 6 4 29
Net Change -14 -5 1 0 17
Cash & Cash Eqvt 9 3 4 4 21

Medicamen Biotech Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 44.83 43.60 43.60 43.60 43.21 43.21 43.21 43.21 43.21
Public 55.17 56.40 56.40 56.40 56.79 56.79 56.79 56.79 56.79
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Medicamen Biotech Ltd. Announcements

View details >>
Sat, 11 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR) - Newspaper Publication
Fri, 10 Nov 2023
Un-Audited Financial Results- Quarter And Half Year Ended September 30 2023
Un-audited Financial Results- Quarter and half year ended September 30 2023
Thu, 02 Nov 2023
Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended On September 30 2023
MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the Unaudited Financial Results for the Quarter and Half Year ended on September 30 2023.

Medicamen Biotech Ltd. Technical Scans

View details >>
Fri, 01 Dec 2023
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
High Decrease in 3 Months High Decrease in 3 Months
CCI Oversold Zone CCI Oversold Zone
Thu, 30 Nov 2023
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low

Medicamen Biotech Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,418.12 1,231.25 +0.4%
Divi's Laboratories Ltd. 100,674.98 3,792.70 +0.1%
Cipla Ltd. 97,418.94 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. 95,866.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. 80,322.42 5,570.00 +0.7%
Mankind Pharma Ltd. 76,800.82 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. 72,809.77 2,151.30 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 75.59 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 28.21 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.83 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.58 2,151.30 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.94 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 3.92 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.36 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.86 2,151.30 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,151.30 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,151.30 +1.1%

Medicamen Biotech Ltd. FAQ's

What is Medicamen Biotech share price?
Can I buy Medicamen Biotech shares now?
What is the Dividend Yield of Medicamen Biotech?
What is the Market Cap of Medicamen Biotech?
What are the key metrics to analyse Medicamen Biotech?
What is the 52 Week High and Low of Medicamen Biotech?
What is the trend of Medicamen Biotech share price?